Overview of Alpha-1 Antitrypsin DeficiencyMediated Liver Disease

Overview of Alpha-1 Antitrypsin DeficiencyMediated Liver Disease

Alpha-1 antitrypsin (AAT), encoded by the SERPINA1 gene, is a protein mainly produced and secreted by hepatocytes. Some specific mutations affecting SERPINA1 may cause accumulation of misfolded AAT in the endoplasmic reticulum of the hepatocytes leading to AAT deficiency (AATD). Z-AAT is the most s...

Full description

Bibliographic Details
Main Authors:	Esra Karatas, Sylvaine Di-Tommaso, Nathalie Dugot-Senant, Alain Lachaux, Marion Bouchecareilh
Format:	Article
Language:	English
Published:	European Medical Journal 2019-05-01
Series:	European Medical Journal Hepatology
Subjects:	alpha-1 antitrypsin deficiency genetic and environmental modifiers liver disease paediatric rare inherited disorder therapeutic strategies
Online Access:	https://www.emjreviews.com/hepatology/article/overview-of-alpha-1-antitrypsin-deficiency-mediated-liver-disease/

Similar Items

Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency
by: Esra Karatas, et al.
Published: (2021-08-01)

Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
by: María Torres-Durán, et al.
Published: (2018-07-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024-02-01)

The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
by: Tobias Meischl, et al.
Published: (2023-01-01)

The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries
by: Celine Leon, et al.
Published: (2021-02-01)

Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01)

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
by: Herth FJF, et al.
Published: (2021-11-01)

Distribution of alpha1 antitrypsin rare alleles in six countries: Results from the Progenika diagnostic network
by: José Luis Lopez-Campos, et al.
Published: (2023-06-01)

Assessing Patients with Alpha-1 Antitrypsin Deficiency for Corneal Refractive Surgery: A Review and Clinical Experience
by: Majid Moshirfar, et al.
Published: (2022-07-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites
by: I. Suárez-Lorenzo, et al.
Published: (2018-11-01)

Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy
by: José Luis López-Campos, et al.
Published: (2020-08-01)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
by: Emanuel Buck, et al.
Published: (2022-01-01)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
by: Simona Viglio, et al.
Published: (2021-01-01)

Alpha 1 antitrypsin deficiency in non cystic fibrosis bronchiectasis
by: Mohamed Shahat Badawy, et al.
Published: (2013-04-01)

Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency
by: Friedrich Kueppers, et al.
Published: (2019-07-01)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
by: Dunlea DM, et al.
Published: (2018-03-01)

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
by: Beiko T, et al.
Published: (2019-07-01)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
by: Marco Mosella, et al.
Published: (2018-01-01)

Diagnosis of alpha-1-antitrypsin deficiency by DNA analysis of children with liver disease
by: De TOMMASO Adriana Maria Alves, et al.
Published: (2001-01-01)

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
by: Rodrigo Russo, et al.

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)

Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
by: Edgar RG, et al.
Published: (2017-05-01)

Alpha-1 Antitrypsin Gene Variants in Patients without Severe Deficiency Diagnosed with Pulmonary Emphysema on Chest CT
by: Laviña E, et al.
Published: (2024-02-01)

Acute Disseminated Panniculitis Associated with Alpha-1 Antitrypsin Deficiency
by: António Guilherme Murinello, et al.
Published: (2022-10-01)

Alpha-1 antitrypsin: now available, but do we need it?
by: Swiss Medical Weekly
Published: (2008-04-01)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma
by: I. Blanco, et al.
Published: (2016-01-01)

COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
by: Myriam Calle Rubio, et al.
Published: (2023-01-01)

A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application
by: Michael E. O’Brien, et al.
Published: (2022-02-01)

Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
by: Seda Tural Onur, et al.
Published: (2022-01-01)

Severe Nocardia pneumonia in an immunocompromised patient with alpha‐1 antitrypsin deficiency
by: Daryl E. C. Y. Chan, et al.
Published: (2020-11-01)

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients
by: Iris G. M. Schouten, et al.
Published: (2021-07-01)

Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic review
by: Ramón A. Tubío-Pérez, et al.
Published: (2021-01-01)

Description of 22 new alpha-1 antitrypsin genetic variants
by: Céline Renoux, et al.
Published: (2018-09-01)

Long-Term SGRQ Stability in a Cohort of Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
by: Choate R, et al.
Published: (2024-04-01)